Hadasit Bio-Holdings Ltd (HSITF)
USD 0.13
(0.0%)
USD 0.13
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.78 Million ILS | 34.75% |
| 2022 | -2.59 Million ILS | 59.56% |
| 2021 | -6.42 Million ILS | -115.83% |
| 2020 | 40.54 Million ILS | 680.46% |
| 2019 | -6.98 Million ILS | -563.34% |
| 2018 | -1.05 Million ILS | 95.54% |
| 2017 | -23.62 Million ILS | -39.85% |
| 2016 | -16.89 Million ILS | 27.09% |
| 2015 | -23.16 Million ILS | -228.61% |
| 2014 | -7.05 Million ILS | 31.04% |
| 2013 | -10.22 Million ILS | -71.0% |
| 2012 | -5.97 Million ILS | 63.82% |
| 2011 | -16.52 Million ILS | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | -436 Thousand ILS | -78.17% |
| 2023 Q4 | -240.15 Thousand USD | 44.92% |
| 2023 FY | -1.69 Million ILS | 34.75% |
| 2023 Q1 | -454.5 Thousand ILS | -15.9% |
| 2023 Q2 | -244.71 Thousand USD | 46.16% |
| 2022 Q2 | -676 Thousand USD | 0.0% |
| 2022 Q1 | -676 Thousand ILS | -22.46% |
| 2022 FY | -2.59 Million ILS | 59.56% |
| 2022 Q4 | -392.15 Thousand USD | 43.17% |
| 2022 Q3 | -690 Thousand ILS | -2.07% |
| 2021 FY | -6.42 Million ILS | -115.83% |
| 2021 Q4 | -552 Thousand ILS | 0.0% |
| 2021 Q3 | -552 Thousand ILS | -12.77% |
| 2021 Q1 | -489.5 Thousand ILS | 14.42% |
| 2021 Q2 | -489.5 Thousand ILS | 0.0% |
| 2020 Q3 | -572 Thousand ILS | 1.12% |
| 2020 FY | 40.54 Million ILS | 680.46% |
| 2020 Q2 | -578.5 Thousand ILS | 0.0% |
| 2020 Q1 | -578.5 Thousand ILS | 42.32% |
| 2020 Q4 | -572 Thousand ILS | 0.0% |
| 2019 Q3 | -1.23 Million ILS | -140.39% |
| 2019 Q1 | -515 Thousand ILS | 0.0% |
| 2019 Q2 | -515 Thousand ILS | 0.0% |
| 2019 FY | -6.98 Million ILS | -563.34% |
| 2019 Q4 | -1 Million ILS | 18.98% |
| 2018 Q1 | 90 Thousand ILS | -99.27% |
| 2018 Q2 | 90 Thousand ILS | 0.0% |
| 2018 FY | -1.05 Million ILS | 95.54% |
| 2017 Q2 | -4.51 Million ILS | 0.0% |
| 2017 FY | -23.62 Million ILS | -39.85% |
| 2017 Q4 | 12.3 Million ILS | 309.43% |
| 2017 Q1 | -4.51 Million ILS | 23.64% |
| 2017 Q3 | -5.87 Million ILS | -30.08% |
| 2016 Q1 | -2.95 Million ILS | 44.35% |
| 2016 Q4 | -5.91 Million ILS | -32.58% |
| 2016 Q3 | -4.46 Million ILS | -25.04% |
| 2016 Q2 | -3.56 Million ILS | -20.87% |
| 2016 FY | -16.89 Million ILS | 27.09% |
| 2015 Q1 | -11.31 Million ILS | -120.84% |
| 2015 Q4 | -5.3 Million ILS | -116.18% |
| 2015 FY | -23.16 Million ILS | -228.61% |
| 2015 Q3 | -2.45 Million ILS | 40.1% |
| 2015 Q2 | -4.09 Million ILS | 63.82% |
| 2014 Q3 | -1.38 Million ILS | -188.1% |
| 2014 Q2 | 1.57 Million ILS | 174.43% |
| 2014 Q4 | -5.12 Million ILS | -270.04% |
| 2014 FY | -7.05 Million ILS | 31.04% |
| 2014 Q1 | -2.11 Million ILS | 64.61% |
| 2013 Q3 | -2.14 Million ILS | 33.28% |
| 2013 FY | -10.22 Million ILS | -71.0% |
| 2013 Q1 | 1.1 Million ILS | 127.93% |
| 2013 Q2 | -3.21 Million ILS | -391.21% |
| 2013 Q4 | -5.96 Million ILS | -178.23% |
| 2012 Q1 | -2.23 Million ILS | 0.0% |
| 2012 FY | -5.97 Million ILS | 63.82% |
| 2012 Q3 | -1.64 Million ILS | -188.79% |
| 2012 Q4 | -3.95 Million ILS | -141.04% |
| 2012 Q2 | 1.84 Million ILS | 182.71% |
| 2011 FY | -16.52 Million ILS | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -27.034% |
| CSL Limited | 3.7 Billion USD | 100.048% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 97.519% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 136.237% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -580.483% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 90.021% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 102.176% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -15.947% |
| Mesoblast Limited | -84.14 Million USD | 97.883% |
| Marizyme, Inc. | -34.08 Million USD | 94.775% |
| Genus plc | 6.4 Million USD | 127.828% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 118.281% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -91.222% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 78.671% |
| ContraFect Corporation | -56.88 Million USD | 96.869% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 60.898% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| IMV Inc. | -38.67 Million USD | 95.395% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 35.256% |
| MultiCell Technologies, Inc. | -722.81 USD | -246299.469% |
| Accustem Sciences Inc. | -3.74 Million USD | 52.461% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 96.981% |
| EV Biologics, Inc. | -483.06 Thousand USD | -268.69% |
| Q BioMed Inc. | -3.44 Million USD | 48.311% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 150.311% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 32.218% |
| Biomind Labs Inc. | -1 Million USD | -76.406% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 73.21% |
| Skye Bioscience, Inc. | -13.67 Million USD | 86.973% |
| SQZ Biotechnologies Company | -75.82 Million USD | 97.651% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -5846.181% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 64.694% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 37.52% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 88.777% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -357.171% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | 63.501% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 10.344% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 7.845% |
| GB Sciences, Inc. | -1.42 Million USD | -25.378% |
| Alpha Cognition Inc. | -9.7 Million USD | 81.65% |
| argenx SE | -425.04 Million USD | 99.581% |
| HST Global, Inc. | -140.9 Thousand USD | -1163.954% |
| Halberd Corporation | -75.05 Thousand USD | -2273.085% |
| Enzolytics Inc. | -2.14 Million USD | 17.117% |
| Resverlogix Corp. | -12.74 Million USD | 86.03% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 43.786% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 96.791% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 96.76% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -70.594% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 38.613% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 38.995% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 4.472% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -12.768% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 47.694% |
| AVAX Technologies, Inc. | 6.69 Million USD | 126.61% |
| ONE Bio Corp. | 13.68 Million USD | 113.018% |
| Zenith Capital Corp. | -8.94 Million USD | 80.085% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.572% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -10123.294% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 27.464% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -938.426% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 11.161% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -58.324% |
| Agentix Corp. | -1.37 Million USD | -29.834% |
| Adynxx, Inc. | - USD | Infinity% |
| Kadimastem Ltd | -3.04 Million USD | 41.419% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -80.986% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -41.799% |
| BioStem Technologies, Inc. | -7.77 Million USD | 77.105% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -881.348% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -33.365% |
| LadRx Corporation | -3.82 Million USD | 53.421% |
| Cell Source, Inc. | -4.32 Million USD | 58.824% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -328.662% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -159.262% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -159.262% |
| NovAccess Global Inc. | -2.46 Million USD | 27.8% |
| Affymax, Inc. | -15.04 Million USD | 88.163% |
| Itoco Inc. | -919.14 Thousand USD | -93.768% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 57.98% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -59.16% |
| CytoDyn Inc. | -18.05 Million USD | 90.137% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -6975.884% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -709.259% |
| Qrons Inc. | -643.67 Thousand USD | -176.692% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -215.376% |
| SYBLEU INC | -149.18 Thousand USD | -1093.86% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | 20.13% |
| Rebus Holdings, Inc. | -664 Thousand USD | -168.223% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 1.945% |
| Mobile Lads Corp. | -554.55 Thousand USD | -221.161% |
| International Stem Cell Corporation | -663 Thousand USD | -168.627% |
| Bioxytran, Inc. | -3.82 Million USD | 53.379% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -3283.359% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -8656.146% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 95.089% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -10.074% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -142.038% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 42.752% |
| Neutra Corp. | -229.48 Thousand USD | -676.082% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 89.845% |
| PureTech Health plc | -146.19 Million USD | 98.782% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 91.713% |
| IXICO plc | -1.43 Million USD | -23.939% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 81.235% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 98.538% |
| CSL Limited | 3.81 Billion USD | 100.047% |
| Cellectis S.A. | -108.85 Million USD | 98.364% |